Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial.

Autor:	Tarcha, Eric J.1, Olsen, Chelsea M.1 colsen@kpitherapeutics.com, Probst, Peter1, Peckham, David1, Muñoz-Elías, Ernesto J.1, Kruger, James G.2, Iadonato, Shawn P.1
Zdroj:	PLoS ONE. 7/19/2017, Vol. 12 Issue 7, p1-19. 19p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu